Untitled 3

Source R&D is the authoritative source of technology and services information supporting pharmaceutical and biotechnology companies in their drug discovery and development research projects.

Source R&D features extensive listings of service providers classified under company or organisation type, including contract chemical manufacturers; contract biologics manufacturers; biological research companies and organisations; and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

The extensive coverage of Source R&D and the support of life sciences organisations One Nucleus and Bionow make it an invaluable reference tool that streamlines the vendor selection process to bring pharmaceutical/biotechnology companies and suppliers together.

AMSBIO expands human endothelial progenitor cell range

UK-based AMSBIO has expanded its catalogue of primary and progenitor cell types and media with a new range of human endothelial progenitor cells (EPCs). These cells are a primitive cell type derived from bone marrow and have properties similar to…
  • Published in Source R&D
  • Read: 404 times

Wickham Laboratories’ FDA accreditation renewed

The FDA inspection of Wickham Laboratories’ facility that took place in February this year has been closed out and the company’s accreditation renewed for a further term. The multi-day inspection assessed Wickham Laboratories’ compliance with Good Manufacturing Practices (GMP) and…
  • Published in Source R&D
  • Read: 374 times

Phage display technology advances immunotherapy research

The Third Annual Display of Antibodies - Empowering Novel Biologics conference taking place from October 31 to November 1 during the PEGS Europe Protein and Antibody Engineering Summit at the EPIC SANA Lisboa Hotel, Lisbon, Portugal (October 31 to November…
  • Published in Source R&D
  • Read: 323 times
Subscribe to this RSS feed